Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces ApoptosisKhoa Pham, Eric H. Raabe, Micah J. Maxwell et al.|Journal of Neuropathology & Experimental Neurology|2021Cited by 27
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Eric H. Raabe, Allison R. Hanaford et al.|Cancers|2022Cited by 21
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastomaRachael Maynard, Eric H. Raabe, Brad Poore et al.|Cancer Letters|2021Cited by 9
BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibitionSu-Chan Lee, Charles G. Eberhart, Satoshi Nakata et al.|Neuro-Oncology|2025Cited by 2
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In <i>Vitro</i> And In <i>Vivo</i> Glucose And Glutamine UsageKhoa Pham, Eric H. Raabe, Brad Poore et al.|Neuro-Oncology Advances|2021Cited by 1